Results 41 to 50 of about 72,300 (203)

Comparison of Fluoroquinolones: Cytotoxicity on Human Corneal Epithelial Cells

open access: yes, 2011
Purpose To compare the cytotoxicity of different fluoroquinolones (FQs) towards human corneal epithelial cells (HCECs). Methods HCECs were incubated with FQs ( norfloxacin, ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, and gatifloxacin), both as ...
蔡紫薰;陳偉勵;胡芳蓉   +1 more
core   +1 more source

Cardiac toxicity of fluoroquinolones and bedaquiline [PDF]

open access: yes, 2019
The review analyzes data on the impact of fluoroquinolones and bedaquiline on the cardiac conduction system. The dependence of the cardiotoxic effect of fluoroquinolones on their influence on the potassium channels of cardiomyocytes is presented.
A. G. Sаmoylovа, G. N. Mozhokinа
core   +1 more source

Dynamics of Staphylococcus Aureus Antibiotic Resistance to Fluoroquinolones in Vitro

open access: yes, 2018
Introduction. S. aureus is the main pathogen of skin, soft tissues and otorhinolaryngological infections as well as the cause of osteomyelitis, meningitis and endocarditis. In recent years the importance of S.
Dukhovych T., Chopey I., Mykhalko Y.
core   +1 more source

Comparison of sensitivities of skin prick and intradermal tests with oral rechallenge test: A prospective interventional hospital-based study

open access: yesIndian Journal of Dermatology, 2021
Background: Identification of culprit drug causing adverse cutaneous drug reactions may not be possible clinically due to the intake of more than one drug.
Satyendra K Singh   +2 more
doaj   +1 more source

Les résistances bactériennes aux fluoroquinolones

open access: yes, 2021
La survenue de résistances bactériennes est en constante augmentation. Il s'agit d'un problème majeur de santé publique. Cet ouvrage centré sur les fluoroquinolones a pour objectif de détailler les connaissances actuelles sur les résistances bactériennes
Delville, Alexia
core   +1 more source

A Rare Instance of Levofloxacin Induced Myoclonus [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Levofloxacin is a widely used fluoroquinolone, mainly as a respiratory antimicrobial agent. It is employed as a second line therapeutic modality in pulmonary tuberculosis as well.
Sushil Kiran Kunder   +3 more
doaj   +1 more source

In-Vitro Adsorption of Fluoroquinolones on Some Pharmaceutical Adsorbents [PDF]

open access: yes, 2007
Purpose: Drug overdose and poisoning are common clinical problems and could occur with the fluoroquinolones – a new series of synthetic antimicrobial agents. It therefore becomes important to study the adsorption of the fluoroquinolones on pharmaceutical
Afolabi, A B, Eboka, C J
core   +1 more source

Recurrent cystitis in women: principles of rational therapy

open access: yesМедицинский совет, 2022
Introduction. Urinary tract infections (UTIs) are one of the most common disease among women.Aim. To determine the efficacy and tolerability of furazidin in the treatment of patients with exacerbation of chronic recurrent cystitis.Material and methods. a 
E. V. Kulchavenya   +2 more
doaj   +1 more source

Pharmacodynamics of fluoroquinolones [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 1999
Abstract Fluctuating concentrations of three fluoroquinolones (moxifloxacin, sparfloxacin and ofloxacin) and a β-lactam (amoxycillin) were used in vitro to simulate antibiotic concentrations in human serum after oral doses of antibiotics.
openaire   +2 more sources

The Use of Systemic and Topical Fluoroquinolones

open access: yes, 2011
Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children becomes better defined. Earlier
null null   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy